V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20208268 | 20088539 | null | 46.3 | Palliative (P) | null | 2019-08-28 | OXALIPLATIN | 02 | N | NIVOLUMAB | 101048154 |
| 20208300 | 20088540 | 1.7 | 70.2 | Palliative (P) | 2017-05-28 | 2017-05-31 | Capecitabine + Streptozocin | 02 | N | EVEROLIMUS | 100224302 |
| 20208403 | 20088541 | null | null | 03 | 2019-10-02 | 2019-10-03 | Fluorouracil + Folinic + RT Bossett | 02 | N | CARBOPLATIN + FLUOROURACIL + TRASTUZUMAB | 101228832 |
| 20208417 | 20088542 | 1.54 | null | Palliative (P) | 2019-08-13 | 2019-09-22 | MITOMYCIN | 01 | N | ERIBULIN | 100486419 |
| 20208428 | 20088543 | 1.72 | 65 | 03 | 2018-01-31 | 2018-02-01 | Capecitabine + Streptozocin | N | N | CAPECITABINE + STREPTOZOCIN | 101514390 |
| 20208450 | 20088544 | 1.7 | 53.2 | 03 | 2020-03-18 | 2020-03-22 | null | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101828578 |
| 20208509 | 20088545 | 1.62 | 85.9 | Palliative (P) | 2019-10-06 | 2019-10-06 | SCOPE 2 TRIAL | 02 | N | MITOMYCIN | 101683036 |
| 20208539 | 20088546 | 1.8 | 67 | Palliative (P) | 2016-11-03 | 2016-11-03 | Bortezomib + CYCLOPHOSPHAMIDE | 99 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101205013 |
| 20208543 | 20088547 | 1.8 | 59.6 | 03 | 2017-05-03 | 2017-05-17 | ST03 TRIAL | 01 | Y | CHLORAMBUCIL + OBINUTUZUMAB | 101352996 |
| 20208547 | 20088548 | 1.74 | 72.4 | 03 | 2017-10-15 | 2017-10-15 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | IRINOTECAN | 101842607 |
| 20208568 | 20088549 | 1.61 | 112 | 03 | 2018-12-16 | 2018-12-29 | DABRAFENIB + TRAMETINIB | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100615101 |
| 20208624 | 20088550 | 1.74 | 48 | Adjuvant (A) | 2020-08-02 | 2020-08-03 | EVEROLIMUS | 01 | N | ARISTOTLE TRIAL | 100157115 |
| 20208734 | 20088551 | 1.82 | 52.1 | Palliative (P) | 2018-10-09 | 2018-10-10 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100594907 |
| 20208758 | 20088552 | 1.66 | 103 | Palliative (P) | 2016-11-23 | 2016-12-28 | ABEMACICLIB + FULVESTRANT | N | N | MELPHALAN + THALIDOMIDE | 100476395 |
| 20208807 | 20088553 | 1.77 | null | Palliative (P) | 2018-07-14 | 2018-07-14 | Pazopanib | 02 | N | RADIUM 223 | 100615052 |
| 20208899 | 20088556 | 1.7 | 81 | 03 | 2018-07-29 | 2018-08-01 | Abiraterone | 02 | N | ACTICCA-1 TRIAL | 100121350 |
| 20208924 | 20088557 | 1.73 | 78.7 | 03 | 2018-10-08 | 2018-10-09 | PACLITAXEL | 01 | null | AFATINIB | 101629550 |
| 20208932 | 20088558 | 1.66 | 60 | Palliative (P) | 2018-10-10 | 2018-10-24 | EOF | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101555902 |
| 20208995 | 20088559 | 1.5 | 58.3 | Adjuvant (A) | 2017-01-31 | 2017-01-31 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | null | PEMBROLIZUMAB | 101485433 |
| 20209190 | 20088561 | 1.57 | 82 | Palliative (P) | 2019-07-09 | 2019-07-26 | Gemcitabine + Paclitaxel | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101189329 |
| 20209216 | 20088562 | 1.75 | 90 | Adjuvant (A) | 2016-10-21 | 2016-11-17 | NEO-AEGIS TRIAL | null | Y | GEMCARBO | 100051258 |
| 20209223 | 20088563 | 1.69 | 63.36 | Adjuvant (A) | 2018-09-18 | 2018-09-21 | PACLITAXEL | 01 | N | CISPLATIN + FLUOROURACIL + RT | 100971050 |
| 20209255 | 20088564 | 1.8 | 63.15 | Palliative (P) | 2018-09-29 | 2018-10-13 | null | 02 | N | ARISTOTLE TRIAL | 100482689 |
| 20209271 | 20088565 | 1.68 | 113 | 03 | 2017-03-05 | 2017-03-05 | Docetaxel 75mg/m2 (21 day) | 01 | N | ACELARATE TRIAL | 101477469 |
| 20209337 | 20088566 | null | null | null | 2020-02-25 | 2020-03-03 | ESPAC-4 TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101106624 |
| 20209372 | 20088567 | 1.7 | 55 | 03 | 2017-04-23 | 2017-05-18 | ECarboX | 02 | Y | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100458643 |
| 20209418 | 20088568 | 0 | 0 | Palliative (P) | 2018-03-01 | 2018-03-01 | CISPLATIN + RT | null | N | FOXTROT TRIAL | 101261389 |
| 20209456 | 20088569 | 1.73 | 84.5 | null | 2017-07-11 | 2017-07-24 | STREPTOZOCIN | 02 | null | CISPLATIN + FLUOROURACIL + RT | 101338801 |
| 20209458 | 20088570 | 1.65 | 72.8 | 03 | 2019-11-15 | 2019-11-15 | Cyclophosphamide + Docetaxel | 02 | N | ABVD | 101664351 |
| 20209528 | 20088571 | 1.73 | 89 | Palliative (P) | 2019-10-18 | 2019-11-07 | FEC 60 or 75 | N | N | IRINOTECAN | 101680228 |
| 20209813 | 20088573 | 1.65 | 88 | 03 | 2016-03-22 | 2016-03-22 | ARISTOTLE TRIAL | 02 | N | OXALIPLATIN | 101671570 |
| 20209863 | 20088574 | 1.58 | 44.1 | 03 | 2019-01-08 | 2019-01-09 | Paclitaxel 7 day | 02 | N | GEMCITABINE + PACLITAXEL | 101409712 |
| 20209873 | 20088575 | 1.67 | 80 | null | 2019-07-23 | 2019-08-05 | EVEROLIMUS | 02 | N | RITUXIMAB | 100225893 |
| 20209918 | 20088577 | 1.68 | 69 | Palliative (P) | null | 2019-04-11 | EEF or EOF | 02 | N | FLUOROURACIL + RT | 101779685 |
| 20210102 | 20088581 | 1.61 | 66.4 | Palliative (P) | 2021-04-07 | 2021-04-07 | Panitumumab | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101689861 |
| 20210130 | 20088582 | 1.74 | 57 | null | 2016-03-06 | 2016-03-13 | PEMBROLIZUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + OXALIPLATIN + PANITUMUMAB | 101476639 |
| 20210144 | 20088583 | 1.62 | 60.6 | 03 | 2016-03-10 | 2016-03-20 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | BORTEZOMIB + DARATUMUMAB | 100131281 |
| 20210205 | 20088584 | 1.82 | 86.6 | Palliative (P) | 2017-11-19 | 2017-11-19 | ACTICCA-1 Trial | N | N | ECARBOF | 100324357 |
| 20210251 | 20088585 | null | 51 | Palliative (P) | 2019-01-30 | 2019-01-30 | FCarboSt | 02 | Y | ACELARATE TRIAL | 100020484 |
| 20210386 | 20088588 | 1.71 | 109 | null | null | 2017-07-20 | Capecitabine + Streptozocin | null | N | BENDAMUSTINE | 101788061 |
| 20210403 | 20088589 | 1.68 | 78.2 | 03 | 2019-09-07 | 2019-09-26 | EVEROLIMUS | 02 | N | GO2 TRIAL | 100930342 |
| 20210425 | 20088591 | 1.66 | 74.75 | 03 | 2019-08-08 | 2019-08-16 | Paclitaxel 7 day | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101715000 |
| 20210432 | 20088592 | 1.62 | 67 | 03 | 2020-06-16 | 2020-07-16 | TAC | 02 | N | ARISTOTLE TRIAL | 100377845 |
| 20210435 | 20088593 | 1.78 | 74 | 03 | 2019-05-07 | 2019-05-31 | NIVOLUMAB | 02 | N | DOCETAXEL | 100028847 |
| 20210453 | 20088594 | 1.97 | 58.4 | Palliative (P) | 2018-02-10 | 2018-02-24 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100708642 |
| 20210468 | 20088595 | 1.58 | 76.4 | Palliative (P) | 2021-06-10 | 2021-06-10 | ECarboX | 02 | N | SCOPE2 TRIAL | 100367677 |
| 20210596 | 20088596 | 1.73 | 71.4 | Palliative (P) | 2018-09-23 | 2018-09-23 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | N | ARISTOTLE TRIAL | 101634328 |
| 20210598 | 20088597 | 1.75 | null | Palliative (P) | 2020-03-21 | 2020-03-28 | FOXTROT TRIAL | 02 | N | BENDAMUSTINE + RITUXIMAB | 100603779 |
| 20210629 | 20088598 | 1.65 | 56.8 | Adjuvant (A) | null | 2020-08-06 | FOXTROT TRIAL | 02 | N | BINIMETINIB + CETUXIMAB + ENCORAFENIB | 101794725 |
| 20210841 | 20088599 | 1.73 | 72.3 | 03 | 2018-04-09 | 2018-04-27 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE | 100112008 |